• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydroxychloroquine-induced restrictive cardiomyopathy: a case report.

作者信息

Dogar Muhammad U, Shah Niel N, Ishtiaq Sameera, Shah Parin N, Shah Pratik, Mathew Shawn, Vittorio Timothy J

机构信息

Department of Medicine, Crozer-Chester Medical Center, Chester, Pennsylvania, USA.

Intern, Smt N. H. L. Municipal Medical College, Ahmedabad, Gujarat, India.

出版信息

Postgrad Med J. 2018 Mar;94(1109):185-186. doi: 10.1136/postgradmedj-2017-135236. Epub 2018 Jan 20.

DOI:10.1136/postgradmedj-2017-135236
PMID:29353247
Abstract
摘要

相似文献

1
Hydroxychloroquine-induced restrictive cardiomyopathy: a case report.羟氯喹诱导的限制性心肌病：一例报告
Postgrad Med J. 2018 Mar;94(1109):185-186. doi: 10.1136/postgradmedj-2017-135236. Epub 2018 Jan 20.
2
Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus.系统性红斑狼疮中羟氯喹诱导的心肌病
J Clin Rheumatol. 2016 Aug;22(5):287-8. doi: 10.1097/RHU.0000000000000400.
3
Hydroxychloroquine-induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment.羟氯喹诱导性心肌病：病例报告、病理生理学、诊断和治疗。
Can J Cardiol. 2014 Dec;30(12):1706-15. doi: 10.1016/j.cjca.2014.08.016. Epub 2014 Aug 23.
4
Evidence for risk of cardiomyopathy with hydroxychloroquine.羟氯喹啉致心肌病风险的证据。
Lupus. 2012 Dec;21(14):1594-6. doi: 10.1177/0961203312462757. Epub 2012 Oct 4.
5
Hydroxychloroquine: a treatable cause of cardiomyopathy.羟氯喹啉：一种可治疗的心肌病病因。
J Am Coll Cardiol. 2012 Aug 21;60(8):786. doi: 10.1016/j.jacc.2011.12.060.
6
Hydroxychloroquine-induced cardiomyopathy in a patient with limited cutaneous systemic sclerosis.羟氯喹诱发的局限性皮肤型系统性硬化症患者的心肌病
Clin Res Cardiol. 2017 Mar;106(3):234-236. doi: 10.1007/s00392-016-1064-z. Epub 2016 Dec 21.
7
Antimalarial-Induced Cardiomyopathy Resembles Fabry Disease on Cardiac MRI.抗疟药所致心肌病在心脏磁共振成像上类似法布里病。
JACC Cardiovasc Imaging. 2020 Mar;13(3):879-881. doi: 10.1016/j.jcmg.2019.09.014. Epub 2019 Nov 13.
8
Hydroxychloroquine Induced Cardiotoxicity: A Case Series.羟氯喹致心脏毒性：病例系列报告。
Rom J Intern Med. 2024 Feb 20;62(2):210-215. doi: 10.2478/rjim-2024-0005. Print 2024 Jun 1.
9
Antimalarial drugs for rheumatoid disease during pregnancy.孕期用于类风湿疾病的抗疟药物。
Can Fam Physician. 1999 Dec;45:2869-70.
10
Endomyocardial biopsy-proven hydroxychloroquine-induced cardiomyopathy in a patient with rheumatoid arthritis.经心内膜心肌活检证实的类风湿关节炎患者应用羟氯喹所致心肌病。
BMJ Case Rep. 2023 Apr 13;16(4):e252327. doi: 10.1136/bcr-2022-252327.

引用本文的文献

1
Hyperuricemia Facilitates Uric Acid-Mediated Vascular Endothelial Cell Damage by Inhibiting Mitophagy.高尿酸血症通过抑制线粒体自噬促进尿酸介导的血管内皮细胞损伤。
Cell Biochem Biophys. 2025 Mar;83(1):811-821. doi: 10.1007/s12013-024-01512-5. Epub 2024 Sep 28.
2
The Effects of Chloroquine and Hydroxychloroquine on ACE2-Related Coronavirus Pathology and the Cardiovascular System: An Evidence-Based Review.氯喹和羟氯喹对ACE2相关冠状病毒病理学及心血管系统的影响：一项基于证据的综述
Function (Oxf). 2020 Jul 27;1(2):zqaa012. doi: 10.1093/function/zqaa012. eCollection 2020.
3
Physiologically-Based Pharmacokinetics Modeling for Hydroxychloroquine as a Treatment for Malaria and Optimized Dosing Regimens for Different Populations.
基于生理的羟氯喹啉治疗疟疾的药代动力学建模及不同人群的优化给药方案
J Pers Med. 2022 May 14;12(5):796. doi: 10.3390/jpm12050796.
4
Systemic Lupus Erythematosus Complicated with Hypertrophic Cardiomyopathy: A Case Report and Literature Review.系统性红斑狼疮合并肥厚型心肌病：一例报告及文献复习
Case Rep Cardiol. 2021 Apr 11;2021:6633085. doi: 10.1155/2021/6633085. eCollection 2021.
5
QTc-interval prolongation and increased risk of sudden cardiac death associated with hydroxychloroquine.羟氯喹可延长 QT 间期并增加心源性猝死风险。
Eur J Prev Cardiol. 2022 Feb 3;28(17):1875-1882. doi: 10.1093/eurjpc/zwaa118.
6
Cardiac Complications Attributed to Hydroxychloroquine: A Systematic Review of the Literature Pre-COVID-19.归因于羟氯喹的心脏并发症：COVID-19 之前的文献系统综述
Curr Cardiol Rev. 2021;17(3):319-327. doi: 10.2174/1573403X16666201014144022.
7
Can HCQ Be Considered a "Safe Weapon" for COVID-19 in the Indian Population?羟氯喹啉能被视为印度人群对抗新冠病毒的“安全武器”吗？
SN Compr Clin Med. 2020;2(8):1057-1063. doi: 10.1007/s42399-020-00392-z. Epub 2020 Jul 10.
8
Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.羟氯喹在 COVID-19 和其他疾病中的安全性：53 项随机试验的系统评价和荟萃分析。
Eur J Clin Pharmacol. 2021 Jan;77(1):13-24. doi: 10.1007/s00228-020-02962-5. Epub 2020 Aug 11.
9
Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update.羟氯喹与新冠病毒病：基于细胞与分子生物学的最新进展
Indian J Clin Biochem. 2020 Jul;35(3):274-284. doi: 10.1007/s12291-020-00900-x. Epub 2020 Jun 10.